Madrigal Pharmaceuticals (MDGL) EBT Margin (2009 - 2026)
Madrigal Pharmaceuticals (MDGL) posted EBT Margin of 13.01% for Q3 2026, up 51.71 percentage points from -38.70% a year earlier and up 28.70 percentage points from the prior quarter.
Powered by 
Analysis
Madrigal Pharmaceuticals (MDGL) EBT Margin (2009 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, EBT Margin at Madrigal Pharmaceuticals was -10.63%, up 28.00 percentage points year-over-year; for FY2025, it was -29.74%, up 228.90 percentage points from FY2024.
- In prior years, Madrigal Pharmaceuticals' EBT Margin was -258.64% in FY2024.
- The Q3 2026 figure stands as the highest quarterly EBT Margin in data going back to Q2 2010.
- On a year-over-year basis, EBT Margin has increased in each of the last six quarters, with an average year-over-year change of +211.76 percentage points over the last six quarters.
- According to Business Quant data, EBT Margin for the three prior quarters was -15.69% (Q2 2026), -29.65% (Q1 2026) and -18.20% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 0.13% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 27.75% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 26.27% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 45.21% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 36.90% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 20.41% |
| 10 | Madrigal Pharmaceuticals | 12.65 Bn | 9.06 Bn | 393.45 Mn | 13.01% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 13.01% |
| Jun 30, 2026 | -15.69% |
| Mar 31, 2026 | -29.65% |
| Dec 31, 2025 | -18.20% |
| Sep 30, 2025 | -38.70% |
| Jun 30, 2025 | -19.87% |
| Mar 31, 2025 | -53.36% |
| Dec 31, 2024 | -57.51% |
| Sep 30, 2024 | -172.04% |
| Jun 30, 2024 | -1,038.20% |
| Dec 31, 2018 | -1,402.78% |
| Sep 30, 2018 | -85.63% |
| Jun 30, 2018 | 1,833.70% |
| Mar 31, 2018 | -480.26% |
| Sep 30, 2016 | -31,325.10% |
| Jun 30, 2016 | -15,142.11% |
| Mar 31, 2012 | -9,908.16% |
| Dec 31, 2011 | -299.12% |
| Sep 30, 2011 | -734.25% |
| Jun 30, 2011 | -886.93% |
API Access
Madrigal Pharmaceuticals EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=MDGL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "MDGL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=MDGL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();